The Centre for Cellular and Molecular Platforms (C-CAMP) and Imperial College London have announced Indegene as the first industry partner of the Indo-UK Life Science Corridor, an initiative aimed at connecting research, entrepreneurship and industry to accelerate life sciences innovation between India and the UK.
Supported through the Imperial Global India initiative, the Corridor seeks to facilitate knowledge exchange, strengthen innovation ecosystems and create pathways for translating research into real-world applications. Under the partnership, Indegene, C-CAMP and Imperial College London will co-develop entrepreneurship programmes and support the exchange of knowledge and talent between the two countries.
As part of the collaboration, Indegene will help define industry challenges and support startup exchanges and ecosystem immersion programmes. The initial focus areas include antimicrobial resistance, diagnostics, digital health, agritech, brain science and mental health.
The announcement was made at the C-CAMP–Imperial joint roundtable on International Partnerships for AI Discovery and Innovation, convened under the Government of Karnataka’s Global Innovation Alliance initiative as part of the Bengaluru Tech Summit 2026.
“Global health challenges cannot be solved in isolation”, said Dr. Taslimarif Saiyed, CEO, C-CAMP. “This understanding was central to our vision for the Indo-UK Life Science Corridor, which connects the complementary innovation ecosystems of Imperial College London and C-CAMP to enable cross-border problem-solving. Exposure to both ecosystems will produce smarter, more scalable, and more accessible innovations relevant to both populations.”
Amanda Wolthuizen, Vice-President (Strategy), Imperial College London, said: “Welcoming Indegene as the first industry partner of the Indo-UK Life Sciences Innovation Corridor is an important moment for this partnership. When we launched the initiative with C-CAMP earlier this year, we wanted to create a platform where research, talent and industry could come together to accelerate new technologies and solve shared global challenges. Indegene’s expertise in life sciences make them an ideal first partner as we strengthen India-UK links and grow our network of industry collaborators.”
Dr. Saurabh Jain, Vice President – Global Delivery Centers, CSR, and Advocacy, Indegene, said, “The next decade of life sciences innovation will be defined by how well we connect science, talent, and industry across borders. This Corridor brings together the strengths of India and the UK, giving promising ideas a clearer path from discovery to real-world impact. The partnership reflects our continued commitment to support deep science, strengthen translation pathways, and help promising innovation reach scale.”
C-CAMP has supported more than 700 startups, which have collectively raised over $720 million and have a cumulative valuation of approximately $2.7 billion. It has enabled more than 6,000 research projects and trained over 2,200 scientific personnel. More than 420 life sciences products are in the market, while C-CAMP startups have filed 1,000 patents and supported over 300 publications. The technologies have reportedly reached more than 70 million lives.
Imperial College London launched Imperial Global India in 2025 to drive science and technology programmes through academic, industrial and innovation partnerships, facilitate two-way STEM talent exchange between India and the UK, and support its growing alumni network in India.
Indegene works across commercial, medical, R&D and safety operations for the life sciences industry. It combines life sciences expertise with AI-embedded platforms and operating models to support complex, regulated workflows for global biopharma companies.